Costa Carlos

CIK 00019391671 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001939167

Recent Transactions

19 trades

Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2025-01-22$4.37/sh+115,000→ 115,000 total
Sale
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-23$10.17/sh−857→ 0 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-09-23−857→ 39,789 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-23$3.72/sh+857→ 857 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-20$3.72/sh+35,756→ 35,756 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-09-20−35,756→ 40,646 total
Sale
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-20$10.04/sh−35,756→ 0 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-09-18−11,574→ 76,402 total
Sale
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-18$10.05/sh−11,574→ 0 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-18$3.72/sh+11,574→ 11,574 total
Sale
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-17$10.04/sh−10,272→ 0 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-17$3.72/sh+10,272→ 10,272 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-09-17−10,272→ 87,976 total
Sale
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-16$10.00/sh−400→ 0 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Common Stock
2024-09-16$3.72/sh+400→ 400 total
Exercise/Conversion
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-09-16−400→ 98,248 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-01-24$3.06/sh+90,000→ 90,000 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2023-01-26+65,000→ 65,000 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2022-08-01+50,000→ 50,000 total

Companies

Foghorn Therapeutics Inc.
Chief People Officer
$FHTX

Recent Filings

Address

500 TECHNOLOGY SQUARE STE #700

CAMBRIDGE, MA, 02139

View on SEC.gov